Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

61. Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia

Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: acute osteomyelitis; complicated urinary tract infections; nosocomial lower respiratory tract infections; bacterial meningitis; and bacteraemia %PDF-1.5 %���� 1 0 obj >>> endobj 2 0 obj > endobj 3 0 obj >/Font >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group >/Tabs/S/StructParents 0>> endobj 4 0 obj > stream x��[�r�F}W���D*���I��v��d׎c{+v

All Wales Medicines Strategy Group2015

62. Interventions for preventing recurrent urinary tract infection during pregnancy.

Interventions for preventing recurrent urinary tract infection during pregnancy. BACKGROUND: Recurrent urinary tract infections (RUTI) are common in women who are pregnant and may cause serious adverse pregnancy outcomes for both mother and child including preterm birth and small-for-gestational-age babies. Interventions used to prevent RUTI in women who are pregnant can be pharmacological (antibiotics) or non-pharmacological (cranberry products, acupuncture, probiotics and behavioural

Cochrane2015

63. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). 25931244 2015 06 20 2015 06 29 2015 10 14 1474-547X 385 9981 2015 May 16 Lancet (London, England) Lancet Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). 1949-56 (...) 10.1016/S0140-6736(14)62220-0 S0140-6736(14)62220-0 Treatment of complicated urinary-tract infections is challenging due to rising antimicrobial resistance. We assessed the efficacy and safety of ceftolozane-tazobactam, a novel antibacterial with Gram-negative activity, in the treatment of patients with complicated lower-urinary-tract infections or pyelonephritis. ASPECT-cUTI was a randomised, double-blind, double-dummy, non-inferiority trial done in 209 centres in 25 countries. Between July, 2011

Lancet2015

64. Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: Acute osteomyelitis, Complicated urinary tract infections, Nosocomial lower respiratory tract infections, Bacterial meningitis, Bacteraemia

Fosfomycin (Fomicyt) - for the treatment of the following infections in adults and children including neonates: Acute osteomyelitis, Complicated urinary tract infections, Nosocomial lower respiratory tract infections, Bacterial meningitis, Bacteraemia

Scottish Medicines Consortium2015

65. Prophylactic antibiotics for children with recurrent urinary tract infections

Prophylactic antibiotics for children with recurrent urinary tract infections Prophylactic antibiotics for children with recurrent urinary tract infections | Position statements and practice points | Prophylactic antibiotics for children with recurrent urinary tract infections | Canadian Paediatric Society Protecting and promoting the health and well-being of children and youth CPS Member Login | Who We Are What We Do Get Involved Education/CPD Publications Careers > Share POSITION STATEMENT (...) Prophylactic antibiotics for children with recurrent urinary tract infections Posted: Feb 6 2015 The Canadian Paediatric Society gives permission to print single copies of this document from our website. For permission to reprint or reproduce multiple copies, please see our . Principal author(s) Joan L Robinson, Jane C Finlay, Mia Eileen Lang, Robert Bortolussi; Canadian Paediatric Society , , Paediatr Child Health 2015;20(1):45-47. Abstract Prophylactic antibiotics for urinary tract infections

Canadian Paediatric Society2015

70. Avycaz (ceftazidime-avibactam) - To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no a

Avycaz (ceftazidime-avibactam) - To treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no a Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - AVYCAZ (ceftazidime-avibactam) Injection Company: Forest Research Institute, Inc

FDA - Drug Approval Package2015

71. Randomised controlled trial: Cranberry capsules (2 taken twice daily for an average 38?days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation

Randomised controlled trial: Cranberry capsules (2 taken twice daily for an average 38?days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation | Evidence-Based Medicine This site uses (...) for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation Article Text Therapeutics/Prevention Randomised controlled trial Cranberry capsules (2 taken twice daily for an average 38 days) reduce the risk of postoperative urinary tract infection in women undergoing benign gynaecological surgery involving intraoperative catheterisation Alexis A Dieter Correspondence to : Dr Alexis A Dieter

Evidence-Based Medicine (Requires free registration)2015

72. Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection

Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection Mitchell MD, O'Donnell JA, Pegues DA, Umscheid CA Record Status This is a bibliographic record (...) of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mitchell MD, O'Donnell JA, Pegues DA, Umscheid CA. Urinalysis and urine culture specimens taken from old versus new urinary catheters in patients with suspected urinary tract infection. Philadelphia: Center for Evidence-based Practice (CEP). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Urinalysis; Urinary Catheters; Urinary Tract

Health Technology Assessment (HTA) Database.2014

73. Urinary tract infection in infants and children: Diagnosis and management

Urinary tract infection in infants and children: Diagnosis and management Urinary tract infection in infants and children: Diagnosis and management | Position statements and practice points | Urinary tract infection in infants and children: Diagnosis and management | Canadian Paediatric Society Protecting and promoting the health and well-being of children and youth CPS Member Login | Who We Are What We Do Get Involved Education/CPD Publications Careers > Share POSITION STATEMENT Urinary tract (...) in the management of urinary tract infections (UTIs) in children. The present statement focuses on the diagnosis and management of infants and children >2 months of age with an acute UTI and no known underlying urinary tract pathology or risk factors for a neurogenic bladder. UTI should be ruled out in preverbal children with unexplained fever and in older children with symptoms suggestive of UTI (dysuria, urinary frequency, hematuria, abdominal pain, back pain or new daytime incontinence). A midstream urine

Canadian Paediatric Society2014

74. Monitoring in vitro antibacterial efficacy of 26 Indian spices against multidrug resistant urinary tract infecting bacteria

Monitoring in vitro antibacterial efficacy of 26 Indian spices against multidrug resistant urinary tract infecting bacteria 28664089 2018 11 13 2213-4220 3 3 2014 Sep Integrative medicine research Integr Med Res Monitoring in vitro antibacterial efficacy of 26 Indian spices against multidrug resistant urinary tract infecting bacteria. 133-141 10.1016/j.imr.2014.04.002 To screen methanolic extracts of 26 commonly used Indian spices against nine species of uropathogenic bacteria ( Enterococcus

Integrative medicine research2014 Full Text: Link to full Text with Trip Pro

75. Urinary Tract Infections in Older Women

Urinary Tract Infections in Older Women 24570259 2014 02 26 2014 03 03 2016 10 25 1538-3598 311 8 2014 Feb 26 JAMA JAMA JAMA patient page. Urinary tract infections in older women. 874 10.1001/jama.2014.1152 Mody Lona L Juthani-Mehta Manisha M eng R01 AG032298 AG NIA NIH HHS United States R01 AG041780 AG NIA NIH HHS United States Patient Education Handout United States JAMA 7501160 0098-7484 AIM IM Aged Female Humans Urinary Tract Infections complications diagnosis drug therapy etiology

JAMA2014 Full Text: Link to full Text with Trip Pro

76. Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection

Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection Mitchell MD, Pegues DA, Umscheid CA Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has (...) been made for the HTA database. Citation Mitchell MD, Pegues DA, Umscheid CA. Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection. Philadelphia: Center for Evidence-based Practice (CEP). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Catheterization; Microbiological Techniques; Sequence Analysis; Urinalysiss; Urinary Tract Infections Language Published English Country of organisation United States English

Health Technology Assessment (HTA) Database.2014

77. Diagnosis and treatment of urinary tract infection in children

Diagnosis and treatment of urinary tract infection in children KHA-CARI MissioN CARING FOR AUSTRALASIANS WITH RENAL IMPAIRMENT Chronic Kidney Disease Guidelines DIAGNOSIS & TREATMENT OF UTI IN CHILDREN STATUS Nov 2014 Nov 2014 Nov 2014 Nov 2014 GUIDELINE SUMMARY . Steven McTaggart, Margie Danchin, Michael Ditchfield, Ian Hewitt, Joshua Kausman, Sean Kennedy, Peter Trnka1, Gabrielle Williams [accepted for publication] doi/10.1111/nep.12349 KHA-CARI Guidelines is located in the Centre for Kidney

Clinical Practice Guidelines Portal2014

78. Urinary tract infection (lower) - women

Urinary tract infection (lower) - women Urinary tract infection (lower) - women - NICE CKS Clinical Knowledge Summaries Share Urinary tract infection (lower) - women - Summary A urinary tract infection (UTI) is usually caused by bacteria from the gastrointestinal tract, most commonly Escherichia coli . Acute, uncomplicated UTI is a benign condition that usually resolves in a few days. Ascending infection can occur, leading to pyelonephritis, renal failure, and sepsis. In pregnant women (...) . Visible haematuria persists after infection has been successfully treated. Non-visible haematuria persists after infection has been successfully treated in a woman over 50 years of age. Visible or non-visible haematuria is associated with persistent or recurrent urinary tract infection in a woman aged 40 years or older. Routine referral is recommended for women with recurrent UTI's: Who have a risk factor for an abnormality of the urinary tract. Who are immunocompromised or who have diabetes. Who have

NICE Clinical Knowledge Summaries2014

79. Urinary tract infection (lower) - men

Urinary tract infection (lower) - men Urinary tract infection (lower) - men - NICE CKS Clinical Knowledge Summaries Share Urinary tract infection (lower) - men - Summary Urinary tract infection (UTI) is infection of any part of the urinary tract, usually by bacteria. The commonest uropathogen causing UTI in adults is Escherichia coli in approximately 90% of cases. UTI in men is generally uncommon, but incidence rates are higher in elderly men and those with risk factors, such as: Abnormalities (...) of urinary tract function (for example indwelling catheter, neurogenic bladder, vesicoureteric reflux) or structure (for example renal tract anatomical abnormalities). Incomplete bladder emptying (caused by prostatic enlargement or a blocked indwelling catheter). Previous urinary tract surgery. Immunocompromised state. Complications may include: Ascending infection, leading to pyelonephritis, perinephric and intrarenal abscess, hydronephrosis, renal failure, or urosepsis. Prostate involvement, leading

NICE Clinical Knowledge Summaries2014

80. Urinary tract infection - children

Urinary tract infection - children Urinary tract infection - children - NICE CKS Clinical Knowledge Summaries Share Urinary tract infection - children - Summary Urinary tract infection (UTI) is illness caused by micro-organisms in the urinary tract. Most UTIs are caused by a single species of bacteria from the gastrointestinal tract. Common organisms causing UTI in children include Escherichia coli (about 75% or more of cases), Klebsiella species, and Staphylococcus saprophyticus . Around 1 (...) tract obstruction. Low risk of serious illness if temperature is less than 38°C with no history of fever and there is no loin pain/tenderness. Intermediate risk of serious illness if they do not satisfy the criteria for being at high or low risk. Have I got the right topic? Age from 0 months to 16 years This CKS topic is based on the National Institute for Health and Care Excellence guideline Urinary tract infection in children: diagnosis, treatment and long-term management [ ]. This CKS topic

NICE Clinical Knowledge Summaries2014